4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Myeloid Leukemia: new trials by email Literature Review of Myeloid Leukemia trials Research Report on Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia Daratumumab/rHuPH20, FT538, Fludarabine - Acute Myeloid Leukemia, Myeloid Leukemia | Phase 1 | Completed | Masonic Cancer Center, University of Minnesota | 9 | 2021-11-03 | 2024-10-24 |
| Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia Arm 1- Dose Escalation, Arm 2- Dose Expansion - Cancer, Hematologic Malignancies | Phase 1 | Completed | Amgen | 35 | 2011-10-04 | 2017-11-06 |
| Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia AZD1152 - Myeloid Leukemia | Phase 1 | Completed | AstraZeneca | 65 | 2006-05-01 | 2010-12-08 |
| HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies Peripheral blood progenitor cell transplant - Graft vs Host Disease, Hematologic Neoplasms | Phase 1 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 35 | 1998-06-01 | 2008-03-04 |
Leukemia, Myeloid (4) · Hematologic Neoplasms (2) · Leukemia, Myeloid, Acute (2) · Graft vs Host Disease (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms by Histologic Type (4) · Leukemia (3) · Neoplasms (3) · Neoplasms by Site (2) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate (1) · Cyclophosphamide (1) · daratumumab (1) · fludarabine (1) · fludarabine phosphate (1)
Amgen (1) · AstraZeneca (1) · Masonic Cancer Center, University of Minnesota (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (4) · France (1) · Italy (1) · Netherlands (1)
Bob Lowenberg, MD, PhD (1) · Joseph Maakaron, MD (1) · Paul Stockman, MD (1)